GWAS of Diabetic Nephropathy: Is the GENIE out of the Bottle?

PLoS Genetics

Volumn 8, Issue 9, 2012, Pages

  Böger, Carsten A ^a   Sedor, John R ^b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; EPIDERMAL GROWTH FACTOR RECEPTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AFF3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

AFF3 GENE; ARTICLE; CHROMOSOME 2; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; ERBB4 GENE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; LONGITUDINAL STUDY; MACROALBUMINURIA; MEDICAL RESEARCH; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PHENOTYPE; REPRODUCIBILITY; SINGLE NUCLEOTIDE POLYMORPHISM;

DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY FAILURE, CHRONIC; NUCLEAR PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84866908876     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1002989     Document Type: Article

References (25)

1. Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, et al. (2010) Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376: 419-430.
2. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, et al. (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358: 2545-2559.
3. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358: 2560-2572.
4. Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, et al. (2011) Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 364: 907-917.
5. Reaven PD, Moritz TE, Schwenke DC, Anderson RJ, Criqui M, et al. (2009) Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis. Diabetes 58: 2642-2648.
6. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2003) Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290: 2159-2167.
7. Seaquist ER, Goetz FC, Rich S, Barbosa J, (1989) Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165.
8. Böger C, Heid I, (2011) Chronic kidney disease: novel insights from genome wide association studies. Kidney Blood Press Res 34: 27-36.
9. Sandholm N, Salem RM, McKnight AJ, Brennan EP, Forsblom C, et al. (2012) New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet 8: e1002921 doi:10.1371/journal.pgen.1002921.
10. Veikkolainen V, Naillat F, Railo A, Chi L, Manninen A, et al. (2012) ErbB4 modulates tubular cell polarity and lumen diameter during kidney development. J Am Soc Nephrol 23: 112-122.
11. Ellis JW, Chen MH, Foster MC, Liu CT, Larson MG, et al. (2012) Validated SNPs for eGFR and their associations with albuminuria. Hum Mol Genet 21: 3293-3298.
12. Placha G, Canani LH, Warram JH, Krolewski AS, (2005) Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis 12: 155-169.
13. Böger C, Chen MH, Tin A, Olden M, Köttgen A, de Boer IH, et al. (2011) CUBN is a Gene Locus for Albuminuria. J Am Soc Nephrol 22: 555-570.
14. Köttgen A, Pattaro C, Böger CA, Fuchsberger C, Olden M, et al. (2010) New loci associated with kidney function and chronic kidney disease. Nat Genet 42: 376-384.
15. Pattaro C, Kottgen A, Teumer A, Garnaas M, Boger CA, et al. (2012) Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet 8: e1002584 doi:10.1371/journal.pgen.1002584.
16. Böger C, Gorski M, Li M, Hoffmann M, Huang C, et al. (2011) Association of eGFR-related loci identified by GWAS with incident CKD and ESRD. PLoS Genet 7: e1002292 doi:10.1371/journal.pgen.1002292.
17. Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, et al. (2008) MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40: 1185-1192.
18. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, et al. (2008) MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40: 1175-1184.
19. Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Köttgen A, et al. (2011) Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 364: 616-626.
20. Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, et al. (2011) Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 43: 321-327.
21. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, et al. (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367: 214-223.
22. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, et al. (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841-845.
23. Remuzzi G, Benigni A, Remuzzi A, (2006) Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 116: 288-296.
24. Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, et al. (2005) The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 54: 2164-2171.
25. Perkins BA, Ficociello LH, Roshan B, Warram JH, Krolewski AS, (2010) In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int 77: 57-64.